SUMMARY
Cancer
investigators frequently conduct studies to examine tumor samples from
pairs of apparently independent primary tumors with a view to
determining if they share a “clonal” origin. The genetic fingerprints of
the tumors are compared using a panel of markers, often representing
loss of heterogeneity (LOH) at distinct genetic loci. In this article we
evaluate candidate significance tests for this purpose. The relevant
information derives from the observed correlation of the tumors with
respect to the occurrence of LOH at individual loci, a phenomenon that
can be evaluated using Fisher’s Exact Test. Information is also
available from the extent to which losses at the same locus occur on the
same parental allele. Data from these combined sources of information
can be evaluated using a simple adaptation of Fisher’s Exact Test. The
test statistic is the total number of loci at which concordant mutations
occur on the same parental allele, with higher values providing more
evidence in favor of a clonal origin for the two tumors. The test is
shown to have high power for detecting clonality for plausible models of
the alternative (clonal) hypothesis, and for reasonable numbers of
informative loci, preferably located on distinct chromosomal arms. The
method is illustrated using studies to identify clonality in
contralateral breast cancer. Interpretation of the results of these
tests requires caution due to simplifying assumptions regarding the
possible variability in mutation probabilities between loci, and
possible imbalances in the mutation probabilities between parental
alleles. Nonetheless, we conclude that the method represents a simple,
powerful strategy for distinguishing independent tumors from those of
clonal origin.
Keywords: Clonality, Permutation test, Second primary cancers
Clonality: A Package for Clonality testing
Statistical Challenges in Testing Clonal